Navigation Links
Georgia physicians' study published in the Journal of Urology
Date:2/27/2013

ATLANTA The March 2013 issue of The Journal of Urology, the official journal of The American Urological Association, includes a study conducted by four physicians from Radiotherapy Clinics of Georgia (RCOG), a Vantage Oncology affiliate. This study, 25 Year Disease Free Survival Rate after Irradiation of Prostate Cancer Calculated with the Prostate Specific Antigen Definition of Recurrence Used for Radical Prostatectomy, is the first-ever to analyze 25 years of follow-up data after radiation therapy treatment for prostate cancer patients.

Frank Critz, M.D., founder and medical director at RCOG, the largest community-based prostate program in the United States, co-wrote this study along with three other RCOG physicians, James Benton, M.D., Philip Shrake, M.D., and Mark Merlin, M.D. The prostate program at RCOG is the only program of its kind to have gathered and maintained a clinical records database for all patients over a 30-year period in a consistent and comprehensive manner.

"This study, the longest after irradiation of prostate cancer, confirms using the surgical PSA definition (PSA <0.2 ng/ml) that results from this program are equal to that of radical prostatectomy, thus giving men a choice of treatment and after 15 year follow up if the PSA is <0.2, late recurrence will be rare."

This research study included 3,546 hormone nave men with prostate cancer treated by I-125 implant followed by external beam radiation. The initial cohort was treated with retropubic implants, and as technology improved, the implant technique was changed to a transperineal template/ultrasound guided approach, which was the technique used in 2,875 of these men. Seventy three percent of men had no evidence of prostate cancer 25 years after this irradiation program. To compare like populations, this study compares patients treated between 1984-2000 to two previous prostatectomy studies which analyze 15 years of follow up data and
'/>"/>

Contact: Logan Moses
LMoses@golinharris.com
404-367-2743
Radiotherapy Clinics of Georgia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. The MS Center of Atlanta Partners with Georgia Partnership for TeleHealth
2. Fourth Annual Georgia Partnership for Telehealth, Inc. Conference, Impacting Lives Through Applied Technology, to be held March 18-20th 2013 in Savannah, Georgia
3. Georgia Partnership for TeleHealth Presents to the FCC in Washington DC
4. Georgia State researcher gets $3.4 million grant to develop vaccine technology against flu, RSV
5. New target to stop cancers spread discovered by Georgia State scientists
6. ShapeMed - http://www.ShapeMed.com - Offers Testosterone Screening for Men in Georgia
7. Halcyon Completes First Acquisition in South Georgia
8. Childcare Network Announces Acquisition of 22 Learning Centers from Children’s Friend of Georgia
9. Metro Atlanta ServiceMasters Team Up to Offer Higher Quality of Water Damage, Mold Removal, Carpet Cleaning and Fire Damage Services to Customers in North Georgia
10. Way to make one-way flu vaccine discovered by Georgia State researcher
11. Piedmont Orthopaedic Complex is First to Provide Baseline Brain Function Test for Athletes in Central Georgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... (PRWEB) August 20, 2014 The ... a five-year, $1.24 million Science Education Partnership Award ... to support NAHN’s collaborative project with the Hispanic ... Health Careers. , This collaborative NIH R25 program ... cultural and linguistic diversity among health professionals by ...
(Date:8/20/2014)... New Jersey (PRWEB) August 20, 2014 ... meeting the needs of an estimated tens of thousands ... of the new Bill A3525—a bill that would expand ... to grow their own cannabis—earlier this summer by State ... training for medicinal quality marijuana is growing. , To ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Verndale is ... Inc. 500|5000 list; an exclusive list ranking the fastest-growing ... are ranked according to their yearly percentage revenue growth ... 8th time on the Inc. 5000 list where it ... Company, Verndale offers its clients a wide range of ...
(Date:8/20/2014)... B. E. Smith, the only full-service ... been retained to lead a national chief operating ... in Hermiston, Ore. The top executive search firm ... recently placed more than 900 healthcare executives into organizations. ... progressive, not-for-profit healthcare organization serving a population of more ...
(Date:8/20/2014)... Biosimilars, which are similar versions of ... abbreviated process, could reap billions in health care ... Inc.’s (AIS) Specialty Pharmacy News offers coverage of ... and Drug Administration’s (FDA) recent acceptance of a ... Drugmaker Sandoz said July 24 that the FDA ...
Breaking Medicine News(10 mins):Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 3Health News:Oaksterdam University to Host Four-Day Educational Marijuana Horticultural Seminar Aug 23-26; Training Fills Information Gap for Medical Marijuana Caregivers and Patients 2Health News:Oaksterdam University to Host Four-Day Educational Marijuana Horticultural Seminar Aug 23-26; Training Fills Information Gap for Medical Marijuana Caregivers and Patients 3Health News:For the 8th Time, Verndale Has Been Honored on the Inc. 5000 List 2Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 2Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 3Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 2Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 3
... Company ... driving growth of EMR business, MARKHAM, ON, Feb. ... (TSX-V: NGH), one of North,America,s fastest growing healthcare software ... Helper business to Netsmart,Technologies Inc., a leading provider of ...
... a response in the adult brain , , FRIDAY, Feb. 29 ... ga-ga when they see a baby? , Scientists report ... up a specific region of the adult brain associated with ... looked at another adult face, suggesting there,s a neural basis ...
... BOTHELL, Wash., Feb. 29 Nastech,Pharmaceutical Company Inc. ... will,host a conference call with investors and security ... Eastern time (8:30 a.m. Pacific time) to,discuss the ... in the live conference call, U.S. residents should,dial ...
... quantify heritability of the disease , , FRIDAY, Feb. 29 (HealthDay ... chronic bronchitis, genes also play a major role in the ... which analyzed data on more than 40,000 twins born in ... percent of the risk for chronic bronchitis and that 14 ...
... published in the February issue of Injury Prevention estimates ... schools in 2005-2007 were directly related to an action ... or disciplinary committee. , Researchers in the Center for ... analyzed data from the 2005-2006 and 2006-2007 National High ...
... under 60 survived longer than people who had single ... double lung transplant leads to longer survival than a ... are in the final stages of chronic obstructive pulmonary ... lung transplants are both recognized as treatment options for ...
Cached Medicine News:Health News:Nightingale announces US$12.3 million sale of its Therapist Helper business 2Health News:Nightingale announces US$12.3 million sale of its Therapist Helper business 3Health News:Nightingale announces US$12.3 million sale of its Therapist Helper business 4Health News:Babies Really Can Light Up Your Life 2Health News:Babies Really Can Light Up Your Life 3Health News:Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, March 3, 2008 2Health News:Genetic Factors for Smoking Boost Chronic Bronchitis Risk 2Health News:When the rules of the game are broken: Research studies sports injuries related to illegal activity 2Health News:Double Lung Transplant Better for Younger COPD Patients 2
(Date:8/19/2014)... MENLO PARK, Calif. , Aug. 19, 2014 ... company") announced today a protocol amendment to allow for expanded ... the U.S. Food and Drug Administration (FDA) and that a ... opened at three clinical trial sites in the ... proceeds of US$2.9 million have been raised through warrant exercise ...
(Date:8/19/2014)... 19, 2014 ,Weight Loss- Market ... 2014, report provides comprehensive insights about phase III pipeline ... objective of the report is to establish the understanding ... drugs across the different countries and regions. While the ... report also provides details on the drug master filings ...
(Date:8/18/2014)... and HERZLIYA-PITUACH, Israel , Aug. 19, 2014 ... North Premier, Stockholm : "IMNP"), a biotechnology ... application to list its common stock on the NASDAQ Capital ... unit of the NASDAQ OMX Group. IMMUNE,s common stock is ... the opening of trading on August 21, 2014 under the ...
Breaking Medicine Technology:DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 2DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 3DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 4DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 5DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 6DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 7Weight Loss Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 2Weight Loss Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 3Weight Loss Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 4Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 2Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 3Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 4
... Dec. 27, 2011 Neuralstem, Inc. (NYSE Amex: ... Food and Drug Administration to advance to Phase Ib in ... NSI-189, for the treatment of major depressive disorder ... the drug in depressed patients. NSI-189 is a proprietary new ...
... Dec. 27, 2011 /PRNewswire-Asia/ -- China Botanic Pharmaceutical ... Botanic" or the "Company"), a developer, manufacturer and ... Medicines ("TCM") in China, today announced that the ... 66th PHARMCHINA fair ("the Fair") recently held in ...
Cached Medicine Technology:Neuralstem's NSI-189 Trial in Major Depressive Disorder Receives FDA Approval to Advance to Phase Ib 2Neuralstem's NSI-189 Trial in Major Depressive Disorder Receives FDA Approval to Advance to Phase Ib 3Neuralstem's NSI-189 Trial in Major Depressive Disorder Receives FDA Approval to Advance to Phase Ib 4China Botanic Exhibits All-Natural Anti-depressant Products at the 66th PHARMCHINA Fair 2China Botanic Exhibits All-Natural Anti-depressant Products at the 66th PHARMCHINA Fair 3
The Redi-glaze spectacle magnifier is an aspheric lens, glazed into a standard Keeler LVA frame....
This set is designed to introduce the low vision practitioner to the Keeler telescopic system....
... Featuring up to 20 ... examination in the vertical, ... plus the option to ... corneal transillumination., ,Filters include ...
Comes complete in its own carrying case. There are 24 lenses, 13mm diameter -6D to +6D in 0.5D steps. Mounted in tough, yet light alloy frame....
Medicine Products: